These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23591721)

  • 1. Is residual renal function and better phosphate control in peritoneal dialysis an answer for the lower prevalence of valve calcification compared to hemodialysis patients?
    Rroji M; Seferi S; Cafka M; Petrela E; Likaj E; Barbullushi M; Thereska N; Spasovski G
    Int Urol Nephrol; 2014 Jan; 46(1):175-82. PubMed ID: 23591721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valvular calcification and left ventricular modifying in peritoneal dialysis patients.
    Rebić D; Rašić S; Hamzić-Mehmedbašić A; Džemidžić J; Kurtalić E
    Ren Fail; 2015; 37(8):1316-22. PubMed ID: 26287980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cardiac valve calcification and inflammation in patients on hemodialysis.
    Torun D; Sezer S; Baltali M; Adam FU; Erdem A; Ozdemir FN; Haberal M
    Ren Fail; 2005; 27(2):221-6. PubMed ID: 15807189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malnutrition as a risk factor for cardiac valve calcification in patients under maintenance dialysis: a cross-sectional study.
    Plytzanopoulou P; Papasotiriou M; Politis P; Parissis C; Paraskevopoulou P; Kehagias I; Goumenos DS; Papachristou E
    Int Urol Nephrol; 2020 Nov; 52(11):2205-2212. PubMed ID: 32964341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients?
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Sanderson JE
    Clin J Am Soc Nephrol; 2009 Oct; 4(10):1629-36. PubMed ID: 19713292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis Patients.
    Rroji M; Spahia N; Seferi S; Barbullushi M; Spasovski G
    Ther Apher Dial; 2017 Oct; 21(5):451-458. PubMed ID: 28714271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis.
    Hüting J
    Chest; 1994 Feb; 105(2):383-8. PubMed ID: 8306733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and risk factors for cardiac valve calcification in Chinese end-stage kidney disease patients on combination therapy with hemodialysis and hemodiafiltration.
    Xiong JQ; Chen XM; Liang CT; Guo W; Wu BL; Du XG
    Ren Fail; 2022 Dec; 44(1):224-232. PubMed ID: 35166181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for aortic valve calcification in patients on regular hemodialysis.
    Petrović D; Obrenović R; Stojimirović B
    Int J Artif Organs; 2009 Mar; 32(3):173-9. PubMed ID: 19440993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Fast Decline of Residual Renal Function in the First Year is a Predictor for Early Withdrawal from Peritoneal Dialysis in Non-Diabetic Patients.
    Wang J; Xie X; Yan X; Yang X; Zhang X; Chen J; Han F
    Kidney Blood Press Res; 2019; 44(1):12-21. PubMed ID: 30808853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Residual Renal Function is Associated With Vascular Calcification in Hemodialysis Patients.
    Chen HC; Chou CY; Jheng JS; Chen IR; Liang CC; Wang SM; Liu JH; Lin SY; Kuo HL; Wang IK; Chang CT; Huang CC
    Ther Apher Dial; 2016 Feb; 20(1):27-30. PubMed ID: 26637989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cardiovascular calcifications in hemodialysis patients: a longitudinal study.
    Dimkovic N; Schlieper G; Jankovic A; Djuric Z; Ketteler M; Damjanovic T; Djuric P; Marinkovic J; Radojcic Z; Markovic N; Floege J
    Int Urol Nephrol; 2018 May; 50(5):939-946. PubMed ID: 29441480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of peritoneal dialysis and hemodialysis on mitral and aortic valve calcification associated mortality: a meta-analysis.
    Chiu KJ; Chen SC; Su WY; Chang YY; Chang KC; Li CH; Wu YJ; Wu DW; Kuo CH
    Sci Rep; 2024 Feb; 14(1):4748. PubMed ID: 38413701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus.
    Mazzaferro S; Coen G; Bandini S; Borgatti PP; Ciaccheri M; Diacinti D; Ferranti E; Lusenti T; Mancini G; Monducci I
    Nephrol Dial Transplant; 1993; 8(4):335-40. PubMed ID: 8390008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors.
    Lang SM; Bergner A; Töpfer M; Schiffl H
    Perit Dial Int; 2001; 21(1):52-7. PubMed ID: 11280496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between residual renal function, protein catabolic rate, and phosphate and magnesium levels in peritoneal dialysis patients.
    Pagé DE; Knoll GA; Cheung V
    Adv Perit Dial; 2002; 18():189-91. PubMed ID: 12402616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of residual renal function using beta-trace protein: Impact of dialysis procedures.
    Bargnoux AS; Buthiau D; Morena M; Rodriguez A; Noguera-Gonzalez ME; Gilbert O; Le Quintrec M; Kuster N; Cristol JP
    Artif Organs; 2020 Jun; 44(6):647-654. PubMed ID: 31951029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Taniguchi M; Yoshida H; Tokumoto M; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of dialysis modalities on the progression of coronary artery calcification in dialysis patients.
    Niu Q; Zhao H; Zuo L; Wang M; Gan L
    BMC Nephrol; 2020 Jul; 21(1):302. PubMed ID: 32711477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypervolemia, hypoalbuminemia and mitral calcification as markers of cardiovascular risk in peritoneal dialysis patients.
    Querido S; Quadros Branco P; Silva Sousa H; Adragão T; Araújo Gonçalves P; Gaspar MA; Barata JD
    Rev Port Cardiol; 2017 Sep; 36(9):599-604. PubMed ID: 28843932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.